"Joining forces to improve health is the basis of our Philosophy"
BGP is actively building networks and pursuing collaborations and partnerships with Biopharmaceuticals companies in order to create value for all stakeholders including patients and health care professionals.
Our business strategy relies on developing new products (Biological products & Vaccines) as the market dynamics go for rising the competition in biologics, and therefore, BGP is able to deliver affordable high-quality products based on market needs, by using the most advanced technology platform.
In-licensing Strategy
Involving the comprehensive lifecycle stages of development, production, registration, and marketing (either through exclusive arrangements or collaborative co-marketing), BGP is actively seeking to establish strategic collaborations. The focus is on engaging with companies interested in the out-licensing of their pioneering products or those featuring patent-protected formulations.
Out-licensing Strategy
BGP offers an out-licensing approach for its products, seeking collaboration with companies interested in jointly developing, registering, marketing, and distributing them in specific regions.
Excellence in cGMP Manufacturing
BGP ensures operational excellence in cGMP manufacturing, utilizing cutting-edge Single Use Technology. Our contract manufacturing guarantees key points, delivering significant client value.
Improve manufacturing time
Prioritization of resources
Easier market entry
Cost reduction
BGP’s vision is to be a regional logistic and a manufacturing hub as a result of Egypt’s trade strategic location between Africa, Europe, Middle East and Asia. From that point we have the responsibility to lead using our capabilities and commitments to help.
BGP is committed to offer high quality products for international markets.
BGP is open to discuss export opportunities with potential partners.
If you are interested in collaboration with BGP, kindly contact us at: bd@biogenericpharma.com